Scribd
Upload
405 views2 pages

Ansimar

The document discusses several classes of drugs used to treat bronchial asthma and pulmonary disease. Adrenergic bronchodilators and phosphodiesterase inhibitors work by increasing cAMP levels, while corticosteroids decrease airway inflammation. Anticholinergics produce bronchodilation by decreasing cGMP levels. Leukotriene receptor antagonists and mast cell stabilizers decrease the release of substances that can contribute to bronchospasm. Potential adverse effects include nausea, vomiting, epigastric pain, headache, irritability, insomnia, tachycardia and hyperglycemia. Nurses should monitor lung sounds, blood pressure, sputum and pulmonary function tests during treatment.

Uploaded by

cop_per
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
405 views2 pages

Ansimar

The document discusses several classes of drugs used to treat bronchial asthma and pulmonary disease. Adrenergic bronchodilators and phosphodiesterase inhibitors work by increasing cAMP levels, while corticosteroids decrease airway inflammation. Anticholinergics produce bronchodilation by decreasing cGMP levels. Leukotriene receptor antagonists and mast cell stabilizers decrease the release of substances that can contribute to bronchospasm. Potential adverse effects include nausea, vomiting, epigastric pain, headache, irritability, insomnia, tachycardia and hyperglycemia. Nurses should monitor lung sounds, blood pressure, sputum and pulmonary function tests during treatment.

Uploaded by

cop_per
Copyright
© Attribution Non-Commercial (BY-NC)
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as DOC, PDF, TXT or read online on Scribd
You are on page 1/ 2

Chapter X Drug Study

NAME OF DRUG THERAPEUTIC ACTION GENERIC Adrenergic NAME: bronchodilators and Ansimar phosphodiesterase inhibitors both work by increasing intracellular level of cyclic-3,5- adenosine monophosphate BRAND NAME: (cAMP); adrenergics Doxofylline by increasing production and phosphodiesterase CLASSIFICATIO inhibitorsby decreasing breakdown. N: Antiasthmatic & Increased levels of cAMP produce COPD bronchodilation.Cortic Preparations osteroids act by decreasing airway inflammation. Anticholinergics(ipratr opium) produce brondhodilation by decreasing intracellular levels ofcyclic guanosine monophosphate (cGMP). Leukotriene receptor antagonists INDICATIONS Bronchial asthma & pulmonary disease w/ spastic bronchial component. CONTRA INDICATIONS Acute MI, hypotension, lactation ADVERSE EFFECT Nausea, vomiting, epigastric pain, cephalalgia, irritability, insomnia, tachycardia, extrasystole, tachypnea, hyperglycemia, albuminuria. NURSING CONSIDERATION >Assess lung sounds, pulse and blood pressure before administration and during peak of medication. Not amount, color, and character of sputum produced. > Monitor pulmonary function tests before initiating therapy and periodically during therapy to determine effectiveness of medication.

andmast cell stabilizers decrease the release of substances that can contribute tobronchospasm.

>

Observe for

paradoxical bronchospasm (wheezing). If conditions occur, withhold medication and notify physician of other health care professional immediately

You might also like